can help change the disease course of MS. People with MS can also take other medications for symptoms, complications, and relapses. Multiple sclerosis (MS) causes neurological symptoms that ...

Biogen and AbbVie have announced the voluntary withdrawal of their multiple sclerosis drug Zinbryta from all markets worldwide following dangerous brain inflammation in seven patients in Europe.

It’s not necessary to treat all MS flare-ups with steroids, though. These medications are generally reserved for severe flare-ups that interfere with your ability to function. Some symptoms of ...

came under fire for delaying its decision on whether the breakthrough drug beta interferon should be available to all MS sufferers on the NHS. Catherine, who had to fight for her right to have the ...

Ocrevus as a first-line treatment for early relapsing MS is better at delaying disease progression than starting with a less ...

On an adjusted basis, Biogen expects 2025 profit between $15.25 and $16.25 per share. It earned $16.47 in 2024 and analysts ...

Medscape Medical News, November 01, 2024 Denali-Sanofi Scraps Mid-stage Study for Multiple Sclerosis Drug Denali Therapeutics said on Thursday its partner Sanofi has discontinued a mid-stage study ...

Prenatal and early life sun exposure is associated with a lower risk for relapse in childhood-onset MS, new findings suggest, ...